Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

ASX/PNV stock hub

ASX/PNV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/PNVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

697.8M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/PNV

In the news

Latest news · ASX/PNV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E48.1

P25 12.9P50 20.4P75 41.2

Trailing P/E71.8

P25 14.2P50 19.2P75 35.1

ROE12.5

P25 -118.7P50 -49.4P75 -1.2

ROIC6

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/PNV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

221

Groups with data

Currency

AUD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	301
Employees Change	47%
Employees Change Percent	18.5
Enterprise value	AUD 686.7M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Medical Devices
Isin	AU000000PNV0
Last refreshed	2026-05-10
Market cap	AUD 697.8M
Price	AUD 1.01
Price currency	AUD
Rev Per Employee	463,425.25x
Sector	Healthcare
Sic	3842
Symbol	asx/PNV
Website	https://polynovo.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.42%
EV Earnings	69.51x
EV/EBIT	159.95x
EV/EBITDA	87.08x
EV/FCF	133.31x
EV/Sales	4.92x
FCF yield	0.74%
Forward P/E	48.1x
P/B ratio	8.39x
P/E ratio	71.78x
P/S ratio	5x
PE Ratio3 Y	146.34x
PE Ratio5 Y	261.85x
PEG ratio	1.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.08%
EBITDA Margin	4.77%
FCF margin	3.69%
Gross margin	87.43%
Gross Profit	AUD 122M
Gross Profit Growth	6%
Gross Profit Growth Q	12.94%
Gross Profit Growth3 Y	11.99%
Gross Profit Growth5 Y	17.78%
Net Income	AUD 9.9M
Net Income Growth	67.3%
Net Income Growth Q	-99.91%
Net Income Growth Years	2%
Net Income Growth3 Y	23.37%
Pretax Margin	2.71%
Profit Margin	7.08%
Profit Per Employee	AUD 32,821
Profitable Years	2
ROA	2.27
Roa5y	-1.25
ROCE	4.27
ROE	12.45
Roe5y	-2.62
ROIC	5.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.49%
Cagr15y	20.07%
Cagr1y	-22.91%
Cagr20y	4.36%
Cagr3y	-12.06%
Cagr5y	-18.33%
EPS Growth	67.55
EPS Growth Q	-99.92
EPS Growth Years	2
EPS Growth3 Y	23.34
FCF Growth3 Y	87.14%
OCF Growth10 Y	52.24%
OCF Growth3 Y	88.66%
Revenue Growth	20.69x
Revenue Growth Q	18.13x
Revenue Growth Quarters	17x
Revenue Growth Years	10x
Revenue Growth3 Y	10.56x
Revenue Growth5 Y	16.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 1.18
Assets	AUD 123.4M
Cash	AUD 29.3M
Current Assets	AUD 69.2M
Current Liabilities	AUD 22.8M
Debt	AUD 18.2M
Debt EBITDA	AUD 2.31
Debt Equity	AUD 0.22
Debt FCF	AUD 3.53
Equity	AUD 83.1M
Interest Coverage	4.68
Liabilities	AUD 40.2M
Long Term Assets	AUD 54.1M
Long Term Liabilities	AUD 17.4M
Net Cash	AUD 11.1M
Net Cash By Market Cap	AUD 1.59
Net Cash Growth	-16.47%
Net Debt EBITDA	AUD -1.67
Net Debt Equity	AUD -0.13
Net Debt FCF	AUD -2.15
Tangible Book Value	AUD 82.6M
Tangible Book Value Per Share	AUD 0.12
WACC	11.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.03
Inventory Turnover	1.35
Net Working Capital	AUD 19.9M
Quick ratio	2.34
Working Capital	AUD 46.4M
Working Capital Turnover	AUD 2.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	254.39%
1Y total return	-22.9%
200-day SMA	1.17
3Y total return	-31.99%
50-day SMA	0.96
50-day SMA vs 200-day SMA	50under200
5Y total return	-63.67%
All Time High	4.08
All Time High Change	-75.25%
All Time High Date	2020-12-21
All Time Low	0.02
All Time Low Change	5,215.79%
All Time Low Date	2008-11-21
ATR	0.04
Beta	1.27
Beta1y	0.38
Beta2y	0.85
Ch YTD	-17.89
High	1.03
High52	1.72
High52 Date	2025-05-14
High52ch	-41.11%
Low	1
Low52	0.87
Low52 Date	2026-03-09
Low52ch	16.76%
Ma50ch	5.06%
Price vs 200-day SMA	-13.45%
RSI	53.16
RSI Monthly	38.68
RSI Weekly	44.13
Sharpe ratio	-0.51x
Sortino ratio	-0.62
Total Return	1.32%
Tr YTD	-17.89
Tr15y	1,453.85%
Tr1m	9.19%
Tr1w	1.51%
Tr3m	10.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD 4.3M
Operating Income Growth	-45.75
Operating Income Growth Q	-63.22
Operating Income Growth3 Y	68.52
Operating margin	3.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	599,140,038%
Net Borrowing	-1,980,000
Shares Insiders	10.46%
Shares Institutions	45.55%
Shares Out	690,842,991
Shares Qo Q	1.1%
Shares Yo Y	-1.32%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD 6.6M
Average Volume	1,727,509.95x
Bv Per Share	0.12
CAPEX	AUD -19.6M
Ch10y	254.4
Ch15y	1,453.8
Ch1m	9.19
Ch1w	1.51
Ch1y	-22.9
Ch20y	134.9
Ch3m	10.38
Ch3y	-31.99
Ch5y	-63.67
Ch6m	-15.48
Change	-2.88%
Change From Open	-1.94
Close	1.04
Days Gap	-0.96
Depreciation Amortization	2,354,000
Dollar Volume	2,090,209.1
Earnings Date	2026-05-21
EBIT	AUD 4.3M
EBITDA	AUD 6.6M
EPS	AUD 0.01
F Score	7
FCF	AUD 5.2M
FCF EV Yield	0.75x
FCF Per Share	AUD 0.01
Financing CF	-1,980,000
Fiscal Year End	June
Founded	1,998
Graham Number	0.19678
Graham Upside	-80.52
Income Tax	AUD -6.1M
Investing CF	-19,360,000
Is Primary Listing	1
Last Earnings Date	2026-02-20
Last Report Date	2025-12-31
Lynch Fair Value	AUD 0.33
Lynch Upside	-66.91
Ma150	1.11
Ma150ch	-9.25%
Ma20	1.01
Ma20ch	-0.3%
Net CF	-1,250,000
Next Earnings Date	2026-05-21
Open	1.03
P FCF Ratio	135.5
P OCF Ratio	28.21
Position In Range	28.57
Ppne	42,616,000
Price Date	2026-05-08
Price EBITDA	AUD 105
Ptbv Ratio	8.45
Relative Volume	1.23x
Revenue	139,491,000x
SBC By Revenue	-1.04x
Share Based Comp	-1,451,000
Tax By Revenue	-4.38x
Tr20y	134.88%
Tr6m	-15.48%
Volume	2,069,514
Z Score	14.79

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/PNV pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/PNV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/PNV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+45.6%

Share of float held by funds and institutions

Insider ownership

+10.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.3%

Negative means the company is buying back shares.

Technical

ASX/PNV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.2

Neutral momentum band

Price vs 200-day MA

-13.5%

50/200-day relationship not available

Beta (5Y)

1.27

More volatile than the market

Sharpe ratio

-0.51

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/PNV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/PNV stock rating?

asx/PNV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/PNV analysis?

The full report lives at /stocks/asx/PNV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/PNV?

The latest report frames asx/PNV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/PNV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.